United Health Products, Inc. (OTC:UEEC) announced financial results for the first quarter ended March 31, 2017. Revenues for the quarter totaled a record $227,129, versus $35,828 for the comparable period last year. The company reported net income of $51,993 ($0.00 per share) for the quarter ended March 31, 2017, versus a loss of $(117,888) ($0.00 per share loss) for the first quarter of 2016.The substantial increase in revenues for the quarter, as compared to the same quarter last year, was due to a significant increase in sales of HemoStyp(R), the company's patented hemostatic gauze for the healthcare and wound care sectors. The company's distributors/partners have successfully expanded their global sales efforts in the dental, veterinarian, retail, and military markets. In 2017, United Health Products has been seeking to expand its product base and as well as to expand into international markets.
"We are pleased with the significant first quarter revenue growth, and attaining profitability," said Douglas K. Beplate, CEO. "However, we have a good deal of work left in order to meet our objectives for this year and beyond, which include: obtaining FDA approval for expanded use of HemoStyp(R); reaching distribution agreements in Europe, South Africa, South Korea and additional Asian markets; and, driving significant additional growth in domestic and international distribution, increasing revenues and net income for the remainder of this year and beyond."
Recent UEEC News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/20/2024 04:52:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 06:00:59 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/30/2024 04:15:05 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/25/2024 06:47:51 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/22/2024 06:38:26 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/15/2024 05:36:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:16:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:05:42 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM